Diabetes screening: Detection and application of saliva 1,5-anhydroglucitol by liquid chromatography-mass spectrometry

18Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Context: Unlike other commonly used invasive blood glucose-monitoring methods, salivadetection prevents patients from suffering physical uneasiness. However, there are few studieson saliva 1,5-anhydroglucitol (1,5-AG) in patients with diabetes mellitus (DM).Objective: This study aimed to evaluate the effectiveness of saliva 1,5-AG in diabetes screeningin a Chinese population.Design and Participants: This was a population-based cross-sectional study. A total of 641subjects without a valid diabetic history were recruited from September 2018 to June 2019.Saliva 1,5-AG was measured with liquid chromatography-mass spectrometry.Main outcome measures: DM was defined per American Diabetes Association criteria. Theefficiency of saliva 1,5-AG for diabetes screening was analyzed by receiver operating characteristiccurves, and the optimal cutoff point was determined according to the Youden index.Results: Saliva 1,5-AG levels in subjects with DM were lower than those in subjects who didnot have DM (both P

Cite

CITATION STYLE

APA

Jian, C., Zhao, A., Ma, X., Ge, K., Lu, W., Zhu, W., … Bao, Y. (2020). Diabetes screening: Detection and application of saliva 1,5-anhydroglucitol by liquid chromatography-mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 105(6), 1759–1769. https://doi.org/10.1210/clinem/dgaa114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free